Skip to main content
. Author manuscript; available in PMC: 2012 Aug 11.
Published in final edited form as: Inflammation. 2004 Oct;28(5):271–278. doi: 10.1007/s10753-004-6050-3

Fig. 2.

Fig. 2

Survival not improved with VEGFT treatment in murine sepsis. C57BL/6 female mice underwent CLP 6 h after receiving either VEGFT 500 μg/mouse (▴, N = 15) or vehicle control (■, N = 12) IP and in equal volumes. Mice were observed at regular time intervals for a total of 72 h. CLP induced a 100% mortality with a median survival of 37 h. Treatment with VEGFT did not significantly alter mortality with a median survival of 28 h. Kaplan–Meier survival analysis was performed.